Nigeria to Receive Long-Acting HIV Prevention Drug Lenacapavir by March 2026
Nigeria is set to receive a groundbreaking long-acting HIV prevention drug, Lenacapavir, by March 2026, in what health authorities describe as a major milestone in the country’s fight against new HIV infections. The development was confirmed by the National Agency for the Control of AIDS (NACA), which disclosed that preparations for the introduction of the…
